Table 1.
Gasdermin genes | Protein expression pattern | Function | Disease association | Therapeutics targeting | ||||
---|---|---|---|---|---|---|---|---|
Human | Mouse | Human | Mouse | Human | Mouse | Human | Drug | Indication |
GSDMA | GsdmA1 GsdmA2 GsdmA3 |
Epithelial cells [bladder (2), gastrointestinal tract (4), skin (5)] | Epithelial cells [bladder (2), gastrointestinal tract (4), skin (5)] | Cell death | Cell death | Asthma (6) Systemic sclerosis (7) |
– | – |
GSDMB | None | Epithelial cells [gastrointestinal tract, bladder, airways, bone marrow, lymphoid tissues (4, 5)] | – | Pyroptosis | – | Asthma (8) Pro-tumoral activity (9) |
– | – |
GSDMC | GsdmC1 GsdmC2 GsdmC3 GsdmC4 |
Epithelial cells (4, 5) (skin, bladder, gastrointestinal tract, female tissues) | Epithelial cells (4, 5) (skin, bladder, gastrointestinal tract, female tissues) | Unknown | Unknown | No clear association |
– | – |
GSDMD | GsdmD | Leukocytes, respiratory system, gastrointestinal tract, bone marrow, liver, gallbladder (4, 5) | Leukocytes, respiratory system, gastrointestinal tract, bone marrow, liver, gallbladder (4, 5) | Pyroptosis | Pyroptosis | Hyper-activation in autoinflammatory diseases (CAPS, FMF) (10) |
Dimethyl-fumarate (11) Disulfiram (12) α-NETA (13) |
Hyper-inflammation Cancer |
GSDME | GsdmE | Gastrointestinal tract, muscle tissues, genital tissues, endocrine tissues (4, 5) | Gastrointestinal tract, muscle tissues, genital tissues, endocrine tissues (4, 5) | Pyroptosis Anti-tumor activity | Pyroptosis Anti-tumor activity | Deafness (14) Tubulo- interstitial fibrosis (15) Cancer (16) |
Disulfiram (12) Z-DEVD-FMK (15) miRNA combined with cetuximab (breast cancer) (17) |
Hyper-inflammation Tubulo- interstitial fibrosis Cancer |
PJVK | Pvjk | Transcript mainly expressed in male tissues and brain (4, 5) | Kidney, testis (4, 5) | Mitochondrial homeostasis Pexophagy (hypothesized) | Mitochondrial homeostasis Pexophagy (14) | Deafness (14) | – | – |